ATE485518T1 - Verfahren zur untersuchung von kolonkarzinom und kolonadenom - Google Patents
Verfahren zur untersuchung von kolonkarzinom und kolonadenomInfo
- Publication number
- ATE485518T1 ATE485518T1 AT04747273T AT04747273T ATE485518T1 AT E485518 T1 ATE485518 T1 AT E485518T1 AT 04747273 T AT04747273 T AT 04747273T AT 04747273 T AT04747273 T AT 04747273T AT E485518 T1 ATE485518 T1 AT E485518T1
- Authority
- AT
- Austria
- Prior art keywords
- colorectal
- tissues
- adenoma
- cancer
- colorectal cancer
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 2
- 206010048832 Colon adenoma Diseases 0.000 title 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract 8
- 201000002758 colorectal adenoma Diseases 0.000 abstract 6
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 2
- 108010044467 Isoenzymes Proteins 0.000 abstract 1
- 108010076118 L-selectin counter-receptors Proteins 0.000 abstract 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 abstract 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 230000019635 sulfation Effects 0.000 abstract 1
- 238000005670 sulfation reaction Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91091—Glycosyltransferases (2.4)
- G01N2333/91097—Hexosyltransferases (general) (2.4.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003296216A JP3805330B2 (ja) | 2003-08-20 | 2003-08-20 | 大腸癌及び大腸腺腫の検査方法 |
| PCT/JP2004/009805 WO2005019827A1 (ja) | 2003-08-20 | 2004-07-09 | 大腸癌及び大腸腺腫の検査方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE485518T1 true ATE485518T1 (de) | 2010-11-15 |
Family
ID=34213585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04747273T ATE485518T1 (de) | 2003-08-20 | 2004-07-09 | Verfahren zur untersuchung von kolonkarzinom und kolonadenom |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7601348B2 (de) |
| EP (1) | EP1674869B1 (de) |
| JP (1) | JP3805330B2 (de) |
| AT (1) | ATE485518T1 (de) |
| CA (1) | CA2536328A1 (de) |
| DE (1) | DE602004029698D1 (de) |
| WO (1) | WO2005019827A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4134047B2 (ja) | 2003-03-19 | 2008-08-13 | 財団法人浜松科学技術研究振興会 | 大腸癌マーカー検出方法 |
| JP4593295B2 (ja) | 2005-01-19 | 2010-12-08 | 独立行政法人科学技術振興機構 | 癌及び腺腫の検査方法 |
| JP2006284298A (ja) * | 2005-03-31 | 2006-10-19 | Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai | 大腸腫瘍の診断方法 |
| WO2007007792A1 (ja) * | 2005-07-12 | 2007-01-18 | Eisai R & D Management Co., Ltd. | 抗体の検出法及び検出キット |
| CN101233243A (zh) * | 2005-08-10 | 2008-07-30 | 财团法人浜松科学技术研究振兴会 | 大肠癌标记的检测方法 |
| EA200870204A1 (ru) * | 2006-01-27 | 2009-04-28 | Юниверсити Оф Массачусетс | Системы и способы производства биотоплива и связанных с этим материалов |
| GB201107466D0 (en) | 2011-05-05 | 2011-06-15 | Loktionov Alexandre | Device and method for non-invasive collection of colorectal mucocellular layer and disease detection |
| CN107573414B (zh) * | 2017-08-14 | 2020-08-07 | 李翀 | 人膀胱癌标志物ag-cd71及其抗体abc71和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0693A (ja) | 1992-04-23 | 1994-01-11 | Otsuka Pharmaceut Co Ltd | モノクローナル抗体 |
| JPH0646878A (ja) | 1992-07-28 | 1994-02-22 | Tosoh Corp | モノクロ−ナル抗体およびその製造法 |
| JP3809277B2 (ja) | 1998-03-05 | 2006-08-16 | 生化学工業株式会社 | Ｎ−アセチルグルコサミン−６−ｏ−硫酸基転移酵素のポリペプチド及びそれをコードするｄｎａ |
| US6365365B1 (en) * | 1998-03-20 | 2002-04-02 | The Regents Of The University Of California | Method of determining whether an agent modulates glycosyl sulfotransferase-3 |
-
2003
- 2003-08-20 JP JP2003296216A patent/JP3805330B2/ja not_active Expired - Fee Related
-
2004
- 2004-07-09 CA CA002536328A patent/CA2536328A1/en not_active Abandoned
- 2004-07-09 DE DE602004029698T patent/DE602004029698D1/de not_active Expired - Lifetime
- 2004-07-09 US US10/568,544 patent/US7601348B2/en not_active Expired - Fee Related
- 2004-07-09 AT AT04747273T patent/ATE485518T1/de not_active IP Right Cessation
- 2004-07-09 WO PCT/JP2004/009805 patent/WO2005019827A1/ja active Application Filing
- 2004-07-09 EP EP04747273A patent/EP1674869B1/de not_active Expired - Lifetime
-
2009
- 2009-09-28 US US12/567,944 patent/US20100015632A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20070196874A1 (en) | 2007-08-23 |
| US20100015632A1 (en) | 2010-01-21 |
| JP3805330B2 (ja) | 2006-08-02 |
| US7601348B2 (en) | 2009-10-13 |
| EP1674869A4 (de) | 2008-05-21 |
| JP2005062125A (ja) | 2005-03-10 |
| EP1674869B1 (de) | 2010-10-20 |
| WO2005019827A1 (ja) | 2005-03-03 |
| EP1674869A1 (de) | 2006-06-28 |
| DE602004029698D1 (de) | 2010-12-02 |
| CA2536328A1 (en) | 2005-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhao et al. | Extracellular vesicles as cancer liquid biopsies: From discovery, validation, to clinical application | |
| Orphanou | The detection and discrimination of human body fluids using ATR FT-IR spectroscopy | |
| Karpathakis et al. | Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor | |
| Pantel et al. | Detection, clinical relevance and specific biological properties of disseminating tumour cells | |
| Jung et al. | Cell-free DNA in the blood as a solid tumor biomarker—a critical appraisal of the literature | |
| ES2706761T3 (es) | Métodos sin marcadores para el aislamiento y análisis de ácidos nucleicos en dispositivos en fase sólida | |
| Vinarskaja et al. | ID4 is frequently downregulated and partially hypermethylated in prostate cancer | |
| Devriese et al. | Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials | |
| Holtkötter et al. | Independent validation of body fluid-specific CpG markers and construction of a robust multiplex assay | |
| Potemski et al. | Ki-67 expression in operable breast cancer: a comparative study of immunostaining and a real-time RT-PCR assay | |
| An et al. | Association between MGMT promoter methylation and breast cancer: A meta-analysis | |
| US20080026394A1 (en) | Methods of detecting one or more cancer markers | |
| WO2014182598A1 (en) | Diagnostic assay combining cellular and cell free nucleic acid | |
| Reddy et al. | Death-associated protein kinase promoter hypermethylation in normal human lymphocytes | |
| ATE485518T1 (de) | Verfahren zur untersuchung von kolonkarzinom und kolonadenom | |
| Chen et al. | Advances in HER2 testing | |
| Li et al. | Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients | |
| Lakhotia et al. | Circulating tumour DNA in B‐cell lymphomas: current state and future prospects | |
| US20150079033A1 (en) | Detection of bladder cancer and recurrent bladder cancer | |
| WO2009019369A3 (fr) | Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal | |
| Suijkerbuijk et al. | Comparison of different promoter methylation assays in breast cancer | |
| Yoo et al. | ras Gene mutations and expression of Ras signal transduction mediators in gastric adenocarcinomas | |
| Nicolò et al. | Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications | |
| JP6876304B2 (ja) | 癌に対する薬物療法の効果の予測方法 | |
| WO2013173478A1 (en) | Screening assay for bladder cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |